Prokidney (PROK) Assets Average (2021 - 2026)

Prokidney's (PROK) quarterly Assets Average came in at $314.2 million in Q1 2026, down 25.83% year-on-year from $423.6 million in Q1 2025, and down 8.56% on a QoQ basis from $343.6 million in Q4 2025.

Prokidney (PROK) Assets Average (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Assets Average data on file, last reported at $314.2 million in Q1 2026.

  • On a quarterly basis, Assets Average fell 25.83% year-over-year to $314.2 million in Q1 2026; TTM through Mar 2026 was $314.2 million, a 25.83% decrease from a year earlier, with the FY2025 full-year figure at $388.3 million, down 9.86% from the prior year.
  • Assets Average for Q1 2026 stood at $314.2 million, down from $343.6 million in the prior quarter.
  • Over the last five years, Assets Average for PROK reached as high as $525.2 million in Q4 2022 and fell as low as $145.5 million in Q1 2022.
  • Historically, Assets Average has averaged $402.3 million across 5 years, with a median of $423.6 million in 2025.
  • Across the five-year window, Assets Average surged 260.06% in 2022 and retreated 25.83% in 2026, its largest moves.
  • Year by year, Assets Average stood at $525.2 million in 2022, then fell by 16.95% to $436.2 million in 2023, then climbed by 4.99% to $457.9 million in 2024, then dropped by 24.97% to $343.6 million in 2025, then dropped by 8.56% to $314.2 million in 2026.
  • Per Business Quant data, the three most recent Assets Average figures were $314.2 million in Q1 2026, $343.6 million in Q4 2025, and $361.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Oculis Holding AG 66,831.58 Bn 66,831.30 Bn - 303.40 Mn
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn - 65.01 Mn
3 Akari Therapeutics 976.78 Bn 976.78 Bn - 40.89 Mn
4 BeOne Medicines 471.48 Bn 466.69 Bn 1.35 Bn 8.37 Bn
5 Vertex Pharmaceuticals 121.78 Bn 114.53 Bn 2.59 Bn 26.06 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn 40.71 Bn
7 Belite Bio 63.06 Bn 63.06 Bn - 795.91 Mn
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.54 Bn 34.53 Bn 959.66 Mn 5.05 Bn
10 Prokidney 96.31 Mn 96.31 Mn - 314.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 314.18 Mn
Dec 31, 2025 343.59 Mn
Sep 30, 2025 361.87 Mn
Jun 30, 2025 389.10 Mn
Mar 31, 2025 423.57 Mn
Dec 31, 2024 457.93 Mn
Sep 30, 2024 486.98 Mn
Jun 30, 2024 443.46 Mn
Mar 31, 2024 404.16 Mn
Dec 31, 2023 436.18 Mn
Sep 30, 2023 468.01 Mn
Jun 30, 2023 489.69 Mn
Mar 31, 2023 506.57 Mn
Dec 31, 2022 525.22 Mn
Sep 30, 2022 391.72 Mn
Jun 30, 2022 250.88 Mn
Mar 31, 2022 145.53 Mn
Dec 31, 2021 145.87 Mn
Sep 30, 2021 126.03 Mn